Showing 20 of 81 recruiting trials for “squamous-cell-carcinoma-of-head-and-neck”
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
👨⚕️ Man Hu, Shandong First Medical University Affiliated Cancer Hospital📍 1 site📅 Started Jan 2026View details ↗
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
👨⚕️ Houda Bahig, MD PhD, Centre hospitalier de l'Université de Montréal (CHUM)📍 1 site📅 Started Aug 2025View details ↗
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
👨⚕️ Yue He, M.D., the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jul 2025View details ↗
A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.
Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
👨⚕️ Santiago Cabezas, M.D., Ph.D., Hospital San Carlos, Madrid📍 11 sites📅 Started Jun 2025View details ↗
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
👨⚕️ Eben L Rosenthal, MD, Vanderbilt University/Ingram Cancer Center📍 1 site📅 Started Apr 2025View details ↗
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
RecruitingNCT06174428 ↗
Validity of Viome's Oral/throat Cancer Test
Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
👨⚕️ Ryan Hughes, MD, Atrium Health Wake Forest Baptist Comprehensive Cancer Center📍 3 sites📅 Started Jan 2025View details ↗
Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas
👨⚕️ Pei-Jen Lou, MD., PhD, National Taiwan University Hospital📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT07448727 ↗
Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT
Intraoral Hypothermia Device for Preserving Taste During Radiation
Page 1 of 5Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →